AMR Emerges as Critical Threat to Surgery
Antimicrobial resistance (AMR) has been identified as one of the most pressing public health challenges, with projections indicating it will directly cause over 35 million deaths between 2025 and 2050. This growing crisis poses a significant threat to surgical care, where effective antibiotics are essential for preventing and treating infections.
Impact on Surgical Outcomes
According to health experts, AMR undermines the safety of routine surgeries by making common infections harder to treat. Without effective antimicrobials, surgical site infections become more difficult to manage, leading to longer hospital stays, higher healthcare costs, and increased mortality. The World Health Organization has warned that AMR could reverse decades of medical progress if not addressed urgently.
Drivers of Resistance
The misuse and overuse of antibiotics in humans, animals, and agriculture are key drivers of AMR. In many regions, antibiotics are prescribed unnecessarily for viral infections, while in agriculture they are used as growth promoters. This accelerates the development of drug-resistant bacteria, reducing the efficacy of existing treatments.
Call for Global Action
Health authorities emphasize the need for coordinated global efforts to combat AMR. Measures include promoting rational antibiotic use, investing in new drug development, improving infection prevention and control, and enhancing surveillance systems. Without immediate action, the burden of AMR will continue to escalate, threatening not only surgical care but also cancer treatment, organ transplants, and other medical procedures reliant on antibiotics.
